PSGL-1 attenuates early TCR signaling to suppress CD8+ T cell progenitor differentiation and elicit terminal CD8+ T cell exhaustion
Cell Reports · 2023-05 · 42 (5) · 112436
DOI: 10.1016/j.celrep.2023.112436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023-05. Verfasst von Jennifer L Hope und 20 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Metabolism and Microenvironment, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA; Im…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Metabolism and Microenvironment, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA; Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discov…
- Division of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
- Cancer Genome and Epigenetics, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
- Cancer Molecular Therapeutics, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
- Department of Medicine, Moores Cancer Center at UC San Diego Health, La Jolla, CA 92037, USA.
- Proteomics Core, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- NIA NIH HHS
- American Association of Immunologists
- Melanoma Research Alliance
- NIH
- U.S. Department of Defense
- American Cancer Society
Zitieren
APA
Hope, J. L., Otero, D. C., Bae, E. A., Stairiker, C. J., Palete, A. B., Faso, H. A., Lin, M., Henriquez, M. L., Roy, S., Seo, H., Lei, X., Wang, E. S., Chow, S., Tinoco, R., Daniels, G. A., Yip, K., Campos, A. R., Yin, J., Adams, P. D., …, & Bradley, L. M. (2023). PSGL-1 attenuates early TCR signaling to suppress CD8+ T cell progenitor differentiation and elicit terminal CD8+ T cell exhaustion. Cell Reports, 42(5), 112436. https://doi.org/10.1016/j.celrep.2023.112436
Vancouver
Hope JL, Otero DC, Bae EA, Stairiker CJ, Palete AB, Faso HA, et al. PSGL-1 attenuates early TCR signaling to suppress CD8+ T cell progenitor differentiation and elicit terminal CD8+ T cell exhaustion. Cell Reports. 2023;42(5):112436. doi:10.1016/j.celrep.2023.112436
BibTeX
@article{Hope2023,
author = {Hope, Jennifer L and Otero, Dennis C and Bae, Eun-Ah and Stairiker, Christopher J and Palete, Ashley B and Faso, Hannah A and Lin, Michelle and Henriquez, Monique L and Roy, Sreeja and Seo, Hyungseok and Lei, Xue and Wang, Eric S and Chow, Savio and Tinoco, Roberto and Daniels, Gregory A and Yip, Kevin and Campos, Alexandre Rosa and Yin, Jun and Adams, Peter D and Rao, Anjana and Bradley, Linda M},
title = {PSGL-1 attenuates early TCR signaling to suppress CD8+ T cell progenitor differentiation and elicit terminal CD8+ T cell exhaustion},
journal = {Cell Reports},
year = {2023},
volume = {42},
number = {5},
pages = {112436},
doi = {10.1016/j.celrep.2023.112436}
}
EUVIMED